Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTAPENEM vs MEROPENEM ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTAPENEM vs MEROPENEM ANHYDROUS: Safety Overview

Metric ERTAPENEM MEROPENEM ANHYDROUS
Total FAERS Reports 4,069 144
Deaths Reported 223 25
Death Rate 5.5% 17.4%
Hospitalizations 1,617 102
Average Patient Age 64.1 yrs 55.0 yrs
% Female Patients 54.5% 44.2%
FDA Approval Date Apr 16, 2018 N/A
Manufacturer Merck Sharp & Dohme LLC Mylan Institutional LLC
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Prescription N/A